BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Our new In Focus on organ-on-a-chip technology is live! CHECK IT OUT

Proteomics

 

The term ‘proteomics’ was first coined in 1994 by Marc Wilkens, who went on to establish the first dedicated proteomics laboratory in 1995. This first definition referred to the large-scale study of proteomes, the entire set of proteins present in a cell type, tissue or organism. The definition has now evolved into a more

Read more...

inclusive definition and often includes other ‘omic’ technologies such as genomics and transcriptomics, all of which fall under the umbrella term ‘multiomics’. The goal of proteomics is to gain an integrated view of biological processes by studying all the proteins in a sample, rather than each one individually.

Proteomic technologies can be used to identify proteins, evaluate the total number of proteins, determine the structure, activity and interactions of proteins, and detect post-translational modifications, such as phosphorylation, which are critical to a protein’s function.

For more information and research papers about the techniques involved in proteomics visit the BioTechniques journal site. 

 

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques